| Mrs Gloria Jean Chrisman, LPN | |
|
2977 Colonel Glenn Highway, Fairborn, OH 45324 | |
| (937) 878-6522 | |
| Not Available |
| Full Name | Mrs Gloria Jean Chrisman |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 2977 Colonel Glenn Highway, Fairborn, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821231945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | PN.131261 IV (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Gloria Jean Chrisman, LPN 2977 Colonel Glenn Highway, Fairborn, OH 45324 Ph: (937) 878-6522 | Mrs Gloria Jean Chrisman, LPN 2977 Colonel Glenn Highway, Fairborn, OH 45324 Ph: (937) 878-6522 |
News Archive
The New York Times: "Researchers reported Wednesday that mammograms can cut the breast cancer death rate by 26 percent for women in their 40s. But their results were greeted with skepticism by some experts who say they may have overestimated the benefit.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
Over half of young adults (18-24 year olds) in Europe take comfort in hearing about people's health experiences that are similar to theirs while less than a quarter of the same age-group trust online health websites and even less (17%) believe they will receive quality and dependable information from online search engines such as Google.
NRAS is delighted to unveil its latest initiative that will help those with the debilitating condition Rheumatoid Arthritis (RA) understand more about the medicines that are used in the treatment and management of this incurable condition.
AMAG Pharmaceuticals, Inc. today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme (ferumoxytol) Injection for intravenous (IV) use.
› Verified 4 days ago